We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+2.95%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$8.49B
AUM Growth
-$96.8M
(-1.1%)
Cap. Flow
-$229M
Cap. Flow
% of AUM
-2.7%
Top 10 Holdings %
Top 10 Hldgs %
17.82%
Holding
2,013
New
45
Increased
399
Reduced
1,471
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$32.4M |
| 2 |
Amgen
AMGN
|
+$13.1M |
| 3 |
Medtronic
MDT
|
+$8.19M |
| 4 |
CELG
Celgene Corp
CELG
|
+$8.07M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$8.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$36.5M |
| 2 |
AGN
Allergan Inc
AGN
|
+$14.1M |
| 3 |
Microsoft
MSFT
|
+$10.4M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$9.41M |
| 5 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$8.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.26% |
| 2 | Technology | 16.97% |
| 3 | Financials | 14.32% |
| 4 | Communication Services | 7.87% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASPX
476
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $2.68M | 0.03% |
26,713
+6,450
| +32% | +$430K |
|
477
Revvity
RVTY
$12.3B
| $2.67M | 0.03% |
52,193
-5,661
| -10% | -$262K |
|
478
Kohl's
KSS
$2.03B
| $2.67M | 0.03% |
34,096
-23,205
| -40% | -$1.58M |
|
479
Amphenol
APH
$188B
| $2.66M | 0.03% |
180,672
-21,352
| -11% | -$299K |
|
480
F5
FFIV
$22.1B
| $2.66M | 0.03% |
23,155
+7,033
| +44% | +$828K |
|
481
Celldex Therapeutics
CLDX
$2.77B
| $2.66M | 0.03% |
6,353
+1,121
| +21% | +$401K |
|
|
ACC
482
DELISTED
American Campus Communities, Inc.
ACC
| $2.65M | 0.03% |
61,761
-1,038
| -2% | -$44.4K |
|
|
TSS
483
DELISTED
Total System Services, Inc.
TSS
| $2.64M | 0.03% |
69,171
-7,916
| -10% | -$290K |
|
|
TYC
484
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $2.63M | 0.03% |
58,412
-11,242
| -16% | -$501K |
|
485
DaVita
DVA
$15.1B
| $2.63M | 0.03% |
32,304
-12,662
| -28% | -$972K |
|
486
Lamar Advertising Co
LAMR
$16.2B
| $2.62M | 0.03% |
44,183
+30,821
| +231% | +$1.76M |
|
487
Trane Technologies
TT
$106B
| $2.61M | 0.03% |
38,344
-4,717
| -11% | -$312K |
|
488
Goodyear
GT
$2.07B
| $2.6M | 0.03% |
95,908
+44,123
| +85% | +$1.15M |
|
|
K
489
DELISTED
Kellanova
K
| $2.59M | 0.03% |
41,836
-4,597
| -10% | -$281K |
|
490
CoreCivic
CXW
$3.1B
| $2.59M | 0.03% |
64,297
-5,289
| -8% | -$208K |
|
491
Quest Diagnostics
DGX
$25.1B
| $2.54M | 0.03% |
33,102
-4,074
| -11% | -$292K |
|
492
Ryder
R
$10.3B
| $2.54M | 0.03% |
26,807
-2,398
| -8% | -$220K |
|
493
Newmont
NEM
$98.2B
| $2.53M | 0.03% |
116,604
-20,656
| -15% | -$483K |
|
494
Fluor
FLR
$7.29B
| $2.53M | 0.03% |
44,217
-2,531
| -5% | -$144K |
|
495
RLJ Lodging Trust
RLJ
$1.87B
| $2.51M | 0.03% |
80,234
-5,367
| -6% | -$177K |
|
|
BMR
496
DELISTED
BIOMED REALTY TRUST INC
BMR
| $2.51M | 0.03% |
110,835
-7,115
| -6% | -$163K |
|
497
CNX Resources
CNX
$4.85B
| $2.5M | 0.03% |
107,572
-10,317
| -9% | -$263K |
|
498
Jefferies Financial Group
JEF
$12.9B
| $2.47M | 0.03% |
124,015
-6,154
| -5% | -$127K |
|
499
H&R Block
HRB
$5.18B
| $2.47M | 0.03% |
77,026
-19,390
| -20% | -$649K |
|
500
NiSource
NI
$22.4B
| $2.46M | 0.03% |
142,042
-21,721
| -13% | -$368K |
|
Similar funds
ProShare Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, ProShare Advisors held 2,013 positions worth $8.49B, down 1.1% from $8.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors's Q1 2015 filing shows 45 new, 399 increased, 1,471 reduced and 95 closed positions. Its largest new stake was Qorvo: 60,564 shares worth $4.83M. The largest sale was Visa, an estimated $36.5M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- ProShare Advisors's largest Q1 2015 buy was Qorvo: 60,564 shares worth $4.83M.
- ProShare Advisors added most to Walgreens Boots Alliance in Q1 2015, an estimated $32.4M increase.
- ProShare Advisors's biggest Q1 2015 reduction was Visa, cutting an estimated $36.5M.
- ProShare Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $14.1M.
- ProShare Advisors's ten largest holdings make up 18% of its $8.49B portfolio in Q1 2015.
- ProShare Advisors opened 45 new positions and closed 95 in Q1 2015.
- ProShare Advisors's portfolio value fell 1.1% quarter-over-quarter to $8.49B.
Based on ProShare Advisors's 13F filing for Q1 2015, filed 8 May 2015.